New drug could tackle deadly pregnancy complication
NCT ID NCT07327255
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests a new drug called EG-101 in 24 healthy women to make sure it is safe before trying it in pregnant women with severe pre-eclampsia, a dangerous condition that causes high blood pressure and organ damage. The study will measure how the drug moves through the body and check for side effects. If successful, this drug could help control the disease and save lives.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRE-ECLAMPSIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could pregnant women safely stop aspirin earlier? new trial investigates
- Eye test and blood markers could spot dangerous pregnancy condition earlier
- Pregnancy complication linked to midlife brain changes?
- A simple nudge after childbirth could transform lifelong health for moms with chronic conditions
- Heart and lung changes in pregnancy could reveal hidden clues to preeclampsia
- Could earlier aspirin save lives in sickle cell pregnancies?